Microglia in the Neurovascular Unit: Blood-Brain Barrier-microglia Interactions After Central Nervous System...

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Microglial cells are central to central nervous system (CNS) inflammation in acute and chronic disorders like stroke, Alzheimer's disease (AD), and Parkinson's disease (PD).
• The blood-brain barrier (BBB) maintains brain homeostasis and its dysfunction triggers neuroinflammation, contributing to cerebrovascular disease pathogenesis.
• The neurovascular unit (NVU) comprises multiple cell types, and BBB-microglia interaction is increasingly recognized as vital for NVU injury response.

Purpose of the Study:

• To review the critical role of blood-brain barrier (BBB)-microglia interactions in neuroinflammation.
• To explore how targeting these interactions could offer therapeutic strategies for CNS inflammatory diseases.

Main Methods:

• Literature review of recent research on BBB function, microglial activation, and neuroinflammation.
• Analysis of studies investigating the interplay between BBB integrity and microglial responses in CNS disorders.
• Synthesis of evidence on the therapeutic potential of targeting BBB-microglia communication.

Main Results:

• BBB dysfunction is a key initiator and modulator of neuroinflammation.
• BBB-microglia interactions dynamically influence the inflammatory response within the CNS.
• Targeting the BBB-microglia axis presents a promising therapeutic avenue.

Conclusions:

• BBB-microglia interactions are critical determinants of neuroinflammation in CNS disorders.
• Understanding and modulating these interactions holds significant therapeutic potential for treating neuroinflammatory conditions.
• Further research into BBB-microglia communication is warranted for developing novel treatments.